top of page


Whether it be recreational, clinical, research-based, or otherwise, psychedelics are being widely used and intensely studied. This blog covers a few of these uses to keep you informed. Enjoy!

Currently, psychedelic medicines are illegal in many states. Some are accessible legally in a clinical setting (Ketamine), while others are currently the subject of research and clinical trials (MDMA and Psilocybin). However, many people are still able to obtain these substances and use them for various reasons.

Recreational and PERSONAL growth USES:

Psychedelic substances are often used recreationally. This could be done alone, in a group, at a concert or festival, in nature, at home, or in any number of settings. Recreational users vary dosage depending on their desired state of being or desired outcome. Micro-dosing is often done on a bi-weekly basis at a nearly imperceptible dose to allow for increased cognition, creativity, focus, improvement of presence, relationships, performance, and to gain clarity and relief from mental ailments like anxiety and depression. In other cases, macro-doses (large) are ingested to experience a more pronounced effect which can result in a profound experience characterized by changes in perception, mood, and hallucinations. Each and every experience can be crafted with appropriate set, setting, intention, and attention, regardless of dose.

Clinical USES:

Ketamine/Esketamine is the only medicine with some psychedelic effects that is legal to carry out clinically in the US, though it does not act as a classical psychedelic. Ketamine, a long-used anesthetic, can be precisely dosed to allow for a psychedelic-like dissociative experience. Though the experience differs in character and feel from a natural psychedelic, it can still aid in a patient's healing journey by allowing shifts in perspective after cutting through an individual's mental ailment at the time (depression, anxiety, etc.). Several states are currently working to allow the use of natural psychedelics in a clinical setting. In the clinical setting, psychedelics are used for the treatment of anxiety, depression, PTSD, trauma, and the like. Oregon recently finalized aspects of their legislation to allow for psychedelic assisted psychotherapy by trained and educated professionals in their state.


Because psychedelic medicines have been tightly-regulated (made illegal) since the late 1960’s, research on psychedelics has only recently experienced a resurgence with Psilocybin and MDMA. Current areas of research in psychedelics include:

  • End of Life Anxiety / Cancer

  • Anxiety

  • Depression

  • PTSD

  • Addiction

  • Nerve and Brain Ailments

  • Post-Stroke Issues

  • Autoimmunity

  • Psychiatric and Behavioral Disorders

  • Alzheimer’s Disease

  • Lyme Disease

  • Cognition

Whatever the use or environment, psychedelics are very powerful medicines. But, anything with great power to heal also has great power to harm if misused. Here at NautHaus Psychedelic Wellness, safety is our top priority and the reason we are dedicated to education on psychedelics and the processes of psychedelic healing.

***Disclaimer: NautHaus Psychedelic Wellness is designed to educate and support those investigating the realm of psychedelics under their own volition. The education and consultation services at NautHaus Psychedelic Wellness focus on safety and wellness, but DO NOT support, recommend, or encourage the use of psychedelic or illegal substances of any kind. Further, though NautHaus Psychedelic Wellness is run by a physician, any and all information and content supplied is intended for EDUCATIONAL USE ONLY and does not constitute medical or legal advice. Any information supplied by NautHaus Psychedelic Wellness should be used at the client's own risk. For any medical information, recommendations, diagnosis or treatment, please contact a licensed medical or mental health professional. No doctor-patient relationship is formed in any of the activities or services conducted at NautHaus Psychedelic Wellness.***DO

My project (52).png
bottom of page